-
Mashup Score: 0Pro-Trump counties now have far higher COVID death rates. Misinformation is to blame - 2 year(s) ago
An analysis by NPR shows that since the vaccine rollout, counties that voted heavily for Donald Trump have had more than twice the COVID mortality rates of those that voted for Joe Biden.
Source: NPR.orgTweet -
-
Mashup Score: 557FDA advisory panel rejects widespread Pfizer booster shots - 3 year(s) ago
WASHINGTON (AP) — An influential federal advisory panel overwhelmingly rejected a plan Friday to offer Pfizer booster shots against COVID-19 to most Americans, dealing a heavy blow to the Biden administration’s effort to shore up people’s protection amid the highly contagious delta variant.
Source: AP NEWSTweet
-
Mashup Score: 212
The Biden administration’s push to introduce widespread vaccine boosters hit a roadblock at a Food and Drug Administration advisory panel, which could still consider a narrower recommendation.
Source: WSJTweet
-
Mashup Score: 0
Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were evaluated in 276 patients with plasma cell neoplasms after vaccination with either the BNT162b2 or the AZD1222 vaccine, on days 1 (before the first vaccine shot), 22, and 50. Patients with MM (n = 213), SMM (n = 38), and…
Source: Blood Cancer JournalTweet
-
Mashup Score: 0Round-up: Six-Year Outcomes of ACL Revision Surgery; and More - 3 year(s) ago
Autoantibody positivity and subclinical synovitis are independent predictors of rheumatoid arthritis among patients presenting with undifferentiated large joint arthritis.
Source: Docwire NewsTweet
-
Mashup Score: 0
5000 Background: Historically, androgen deprivation therapy (ADT) was the standard of care (SOC) for men with mCSPC. Since 2015, combining ADT with either docetaxel, novel hormonal therapies, or radiotherapy to the primary tumor (RXT) (for those with low burden metastases) was shown to improve overall survival (OS) and thus has become the new SOC. It is unknown whether combining these new…
Source: Journal of Clinical OncologyTweet
-
Mashup Score: 0
1001 Background: The Phase III MONALEESA-3 trial (NCT02422615) previously demonstrated a statistically significant improvement in OS with RIB, a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i), plus FUL compared with placebo (PBO) plus FUL as first-line (1L) or second-line (2L) treatment in postmenopausal pts with HR+/HER2− ABC (median, not reached vs 40.0 mo; hazard ratio [HR], 0.72; 95% CI,…
Source: Journal of Clinical OncologyTweet
-
Mashup Score: 103COVID-19 Update: CDC Advisers to Meet Today to Review Blood Clot Cases in People Who Received Johnson & Johnson Vaccine; and more - Docwire News - 3 year(s) ago
On Wednesday, April 14, 2021, here are the latest COVID-19 numbers around the world, according to statistics aggregator, Worldometer. World Cases: Over
Source: Docwire NewsTweet
-
Mashup Score: 138Opinion | Covid Arsenal Needs Pills as Well as Shots - 3 year(s) ago
A drug that could prevent severe symptoms could help those who can’t or won’t get vaccinated.
Source: WSJTweet
-
Mashup Score: 0An ode to T cells: their ability to defang virus, fight variants, and have durability - 3 year(s) ago
Thread by @MonicaGandhi9: Wanted to drill down a bit more about the importance of the T-cell response to SARS-CoV-2 to give you more reassurance of enduring protection from vaccines (even against variants). Technic……
Source: threadreaderapp.comTweet